A year ago, an independent expert panel presented a damning report to the World Health Organization's main annual assembly complaining that poor coordination and bad decisions had allowed the Covid pandemic to swell to such a catastrophic scale.
Ever-increasing pressure on India to agree to harmful intellectual property provisions in this trade agreement is particularly concerning, as competition from Indian generic medicine manufacturers has been instrumental in bringing the price of life-saving first-line HIV medicines down by 99% since 2001.”
Public health groups globally have slammed it on grounds that it gives monopoly protection to pharma companies, especially for biologic drugs.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
